Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques. This edition has expanded thoracic oncology chapters including thymus, mesothelioma, and mediastinal tumors, more detailed discussion of targeted agents, and state-of-the-art information on newer techniques in radiotherapy. Other highlights include more international contributors and greater discussion of changes in lung cancer management in each region of the world. A new editor, Giorgio Scagliotti, MD from the University of Turin, has coordinated the accounts of European activities. A companion website includes the full text online and an image bank.

Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques. This edition has expanded thoracic oncology chapters including thymus, meso.

Cancer of any kind is scary, but lung cancer is unique in that most people think that only people who smoke can or do get it. The truth is that anyone can get lung cancer, and it can be deadly. In 2008 (the most recent year numbers are available), 208,493 people in the United States were diagnosed with lung cancer, while 158,592 people in the United States died from lung cancer. Here, Dr. Naheed Ali dispels the notion that only smokers develop lung cancer, but also goes over their increased risk for getting the disease, while also considering the risk factors that non-smokers face. He provides background and tips for combating lung cancer, from prevention, to treatment, to coping with the disease should a person fall victim. In typical fashion, Ali helps readers to understand what lung cancer is, how it develops, its different forms, and how both patients and caregivers can approach healing and treatment. Offering a clear background on the disease and its development, this work will help lung cancer sufferers and their friends and family better cope with and understand the diagnosis.

Carcinoma of the lung is one of the most prevalent and aggressive types of cancer, and rates of lung cancer are on the rise. This issue gives a comprehensive review of the most recent advances in Lung Cancer. Epidemiology, etiology, and prevention of lung cancer is first discussed, followed by articles on pre-invasive evaluation and management, screening, pathology and molecular biology. There is an article on the approach to the ground glass nodule. Of great importance is the revised staging classification of Lung Cancer, which is discussed here in detail. Articles on PET imaging, interventional pulmonary, and functional evaluation before Lung Resection are also included. The issue then focuses on advances in treatment for early stage lung cancer, high risk patients with early stage lung cancer, advances in the treatment of Advanced Stage Lung Cancer, Small Cell Lung Cancer, and gene therapy for lung neoplasms.

New Strategies Targeting Cancer Metabolism: Anticancer Drugs, Synthetic Analogues and Antitumor Agents presents up-to-date synthetic strategies for three categories of antimetabolites: antifolates, purines and pyrimidines, the main classes of antimetabolites which are integrated into various pharmaceutical agents. Many of these antimetabolites are considered potent chemotherapeutic agents which have great potential impact on medical research. These main classes of antimetabolites are used in the treatment of critical diseases including cancer, malignancies, autoimmune diseases, and many other non-malignant diseases. Antineoplastic drugs such as alkylating agents which have significant effects are described. Novel synthetic strategies for many anticancer alkylating agents including nitrogen mustards, chlorambucil, melphalan, ifosamide, oxaliplatin and temozolomide are explored. Natural products have offered some of the most significant drugs for treating cancer, as many drugs currently in clinical use are derived from natural products as camptothecins, vinca alkaloids, and derivatives of podophyllotoxin. They provide a contribution that is essential for modern drug discovery and development. In this book, insights into a broad array of novel compounds are reviewed, well-recognized synthetic approaches are emphasized for further anticancer drug development and discovery, and the biological evaluation of novel synthesized compounds are included. This comprehensive reference is a valuable resource for medical chemists working in drug discovery and development, as well as pharmacologists and biochemists working in related fields. - Provides the only resource dedicated to synthetic strategies of antimetabolites - Features synthetic strategies for nucleosides and their analogues - Includes coverage of purine-, pyrimidine- and antifolate-based anticancer drugs - The most significant anticancer alkylating agents and natural products are demonstrated

The Second Edition of TNM Staging Atlas with Oncoanatomy has been updated to include all new cancer staging information from the Seventh Edition of the AJCC Cancer Staging Manual. The atlas presents cancer staging in a highly visual rapid-reference format, with clear full-color diagrams and TNM stages by organ site. The illustrations are three-dimensional, three-planar cross-sectional presentations of primary anatomy and regional nodal anatomy. They show the anatomic features identifiable on physical and/or radiologic examination and the anatomic extent of cancer spread which is the basis for staging. A color code indicates the spectrum of cancer progression at primary sites (T) and lymph node regions (N). The text then rapidly reviews metastatic spread patterns and their incidence. For this edition, CT or MRI images have been added to all site-specific chapters to further detail cancer spread and help plan treatment. Staging charts have been updated to reflect changes in AJCC guidelines, and survival curves from AJCC have been added.

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today's best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies. - Offers practical, relevant coverage of basic science, epidemiology, pulmonology, medical and radiation oncology, surgery, pathology, palliative care, nursing, and advocacy. - Provides authoritative guidance from the IASLC – the only global organization dedicated to the study of lung cancer. - Includes new content on molecular testing, immunotherapy, early detection, staging and the IASLC staging system, surgical resection for stage I and stage II lung cancer, and stem cells in lung cancer. - Features a new full-color design throughout, as well as updated diagnostic algorithms. - Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, Q&As, and references from the book on a variety of devices.

Modern anatomical medical imaging technologies, such as computed tomography and magnetic resonance, capture structures of the human body in exquisite detail. Computational anatomy is a developing discipline to extract and characterize the anatomy from images. Unfortunately, anatomical images do not reveal the functional behavior. Computational physiology shows great potential to link the structure-function relationship by considering both the anatomical information and the physical governing laws. The simulated physiology can be used to assess physiological states, and more importantly predict the outcomes of interventions. On the other hand, advances in the functional imaging techniques provide measured physiology information and should be utilized together with computational physiology. In the theme of computational anatomy and physiology, this dissertation describes computational methods of modeling vascular geometry for image-based blood flow computation and tracking pulmonary motion for image-guided radiation therapy. Blood flow computation is a useful tool to quantify in vivo hemodynamics. The essential first step is to model vascular geometry from medical imaging data. I have developed a new workflow for this task. The geometric model construction is based on 3D image segmentation and geometric processing. To represent the topology of the constructed model, I have developed a novel centerline extraction method. To account for compliant vessels, methods to assign spatially-varying mechanical properties of the vessel wall are also developed. The workflow greatly increases the modeling efficiency. The combination of the patient-specific geometry and wall deformation can enhance the fidelity of blood flow simulation. Image-based blood flow computation also holds great promise for device design and surgical procedure evaluation. Next, I have developed novel virtual intervention methods to deploy stents or stent grafts to patient-specific pre-operative geometric models constructed from medical images. These methods enable prospective model construction and may be used to evaluate the outcomes of alternative treatment options. Respiratory motion is closely related to the physiology of the lung. Finally, I have developed a novel framework to track patient-specific pulmonary motion from 4D computed tomography images. A large set of vascular junction structures in the lung are identified as landmarks and tracked to obtain their motion trajectories. This framework can provide accurate motion information, which is important in radiation therapy to reduce healthy tissue irradiation while allowing target dose escalation. This work demonstrates the importance of the geometry and motion modeling tools in computational anatomy and physiology. Accurate physiological information, whether simulated or measured, will benefit the diagnosis and treatment of various diseases.

The fourth edition of this bestseller presents extensive background and basic information, state-of-the-art technologies, important achievements, and lingering challenges in the fields of gene and cell therapies. It continues to provide the most comprehensive coverage of these fields in one volume. Some chapters have expanded introductions, making the book even more suitable for classroom use. This edition also offers more material on the contributors' research efforts as well as current technologies, disease targets, and clinical applications.